Isoptin: Advanced Calcium Channel Blockade for Hypertension Control
Isoptin
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.33 | $40.00 (0%) | 🛒 Add to cart |
| 60 | $0.95 | $80.00 $57.00 (29%) | 🛒 Add to cart |
| 90 | $0.83 | $120.00 $75.00 (38%) | 🛒 Add to cart |
| 120 | $0.78 | $160.00 $93.00 (42%) | 🛒 Add to cart |
| 180 | $0.71 | $240.00 $127.00 (47%) | 🛒 Add to cart |
| 270 | $0.66 | $360.00 $179.00 (50%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $480.00 $232.00 (52%) | 🛒 Add to cart |
| Product dosage: 240mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.73 | $52.00 (0%) | 🛒 Add to cart |
| 60 | $1.30 | $104.00 $78.00 (25%) | 🛒 Add to cart |
| 90 | $1.17 | $156.00 $105.00 (33%) | 🛒 Add to cart |
| 120 | $1.08 | $208.00 $130.00 (38%) | 🛒 Add to cart |
| 180 | $1.01 | $312.00 $182.00 (42%) | 🛒 Add to cart |
| 270 | $0.97 | $468.00 $262.00 (44%) | 🛒 Add to cart |
| 360 | $0.94
Best per pill | $624.00 $338.00 (46%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.00 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $64.50 $53.00 (18%) | 🛒 Add to cart |
| 120 | $0.52 | $86.00 $62.00 (28%) | 🛒 Add to cart |
| 180 | $0.46 | $129.00 $82.00 (36%) | 🛒 Add to cart |
| 270 | $0.41 | $193.50 $110.00 (43%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $258.00 $139.00 (46%) | 🛒 Add to cart |
Isoptin (verapamil hydrochloride) is a premium calcium channel blocker medication engineered for precise cardiovascular management. Developed through advanced pharmaceutical research, it targets vascular smooth muscle and cardiac cells to reduce peripheral resistance and myocardial workload. This first-line antihypertensive agent offers predictable pharmacokinetics and a well-established safety profile, making it a cornerstone therapy in modern cardiology practice. Its mechanism provides both blood pressure control and antianginal protection through physiologically rational pathways.
Features
- Contains verapamil hydrochloride as the active pharmaceutical ingredient
- Available in immediate-release (80 mg, 120 mg) and extended-release formulations (120 mg, 180 mg, 240 mg)
- Exhibits calcium ion antagonism on L-type channels in vascular smooth muscle and myocardium
- Demonstrates high oral bioavailability with extensive hepatic metabolism via cytochrome P450 3A4
- Provides concentration-dependent vasodilation and negative chronotropic effects
- Features pH-stable formulation ensuring consistent gastrointestinal absorption
Benefits
- Achieves significant reduction in systolic and diastolic blood pressure through decreased peripheral vascular resistance
- Reduces myocardial oxygen demand through afterload reduction and mild negative inotropy
- Provides antianginal effects by improving coronary blood flow and reducing cardiac workload
- Offers rhythm control benefits for certain supraventricular arrhythmias through slowed AV nodal conduction
- Demonstrates nephroprotective potential in hypertensive patients with proteinuria
- May reduce left ventricular hypertrophy regression in long-term hypertension management
Common use
Isoptin is primarily indicated for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also approved for the treatment of chronic stable angina pectoris and for the control of ventricular rate in atrial fibrillation and flutter. Off-label uses include prophylaxis of migraine headaches, management of hypertrophic cardiomyopathy, and treatment of certain tachyarrhythmias. The medication is particularly valuable in patients with coexisting hypertension and angina, where it addresses both conditions through its dual mechanism of action.
Dosage and direction
Dosage must be individualized based on therapeutic response and tolerability. For hypertension: Initial dose is 80 mg three times daily (immediate-release) or 180-240 mg once daily (extended-release). Maximum daily dose should not exceed 480 mg. For angina: Initial dose is 80-120 mg three times daily. For arrhythmias: Dosage ranges from 240-480 mg daily in divided doses. Administration with food may minimize gastrointestinal discomfort. Extended-release tablets must be swallowed whole without crushing or chewing. Regular blood pressure monitoring is essential during dosage titration.
Precautions
Patients should be monitored for potential development of heart failure symptoms, particularly those with pre-existing ventricular dysfunction. Regular assessment of liver function is recommended due to extensive hepatic metabolism. Electrolyte status should be evaluated periodically, especially in patients receiving concomitant diuretics. Caution is advised in patients with neuromuscular transmission disorders (myasthenia gravis, Duchenne muscular dystrophy) due to potential exacerbation. Abrupt withdrawal should be avoided to prevent rebound hypertension or angina exacerbation.
Contraindications
Isoptin is contraindicated in patients with severe left ventricular dysfunction, cardiogenic shock, sick sinus syndrome, or second- or third-degree AV block (unless a functioning ventricular pacemaker is present). Additional contraindications include hypotension (systolic pressure <90 mmHg), atrial flutter/fibrillation with accessory pathway (WPW syndrome), and known hypersensitivity to verapamil or any component of the formulation. Concomitant use with ivabradine is absolutely contraindicated.
Possible side effect
Common adverse reactions include constipation (7-25%), dizziness (3-10%), nausea (2-7%), hypotension (2-5%), and peripheral edema (1-5%). Less frequent effects include headache, fatigue, bradycardia, and flushing. Serious but rare side effects include heart failure exacerbation, hepatotoxicity, AV block, and gingival hyperplasia with long-term use. Most side effects are dose-dependent and often diminish with continued therapy. Constipation can frequently be managed with appropriate dietary measures or stool softeners.
Drug interaction
Isoptin exhibits significant interaction potential due to CYP3A4 metabolism and P-glycoprotein inhibition. Concomitant use with beta-blockers may produce additive negative chronotropic and inotropic effects. Co-administration with digoxin increases digoxin concentrations by 50-75%. Statins metabolized by CYP3A4 (simvastatin, lovastatin) may experience increased exposure. Potent CYP3A4 inhibitors (ketoconazole, clarithromycin) can significantly increase verapamil levels. Interaction with lithium may enhance neurotoxicity. Concomitant dantrolene administration may precipitate hyperkalemia.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed administration. For extended-release formulations, consistency in dosing time is particularly important to maintain stable plasma concentrations. Healthcare providers should be consulted if multiple doses are missed.
Overdose
Verapamil overdose presents with profound hypotension, bradycardia, and conduction abnormalities. Symptoms may progress to heart failure, cardiogenic shock, or asystole. Management includes gastric lavage if presentation is early, activated charcoal, and aggressive supportive care. Calcium gluconate (1-3 g IV) is the primary antidote. Vasopressors (norepinephrine), inotropes (dobutamine), and glucagon may be required. Temporary pacing may be necessary for severe bradycardia or heart block. Hemodialysis is not effective due to high protein binding.
Storage
Store at controlled room temperature (20-25°C/68-77°F) in the original container protected from light and moisture. Keep tightly closed and away from excessive heat or humidity. Do not store in bathroom cabinets where moisture levels fluctuate. Keep all medications out of reach of children and pets. Do not use if tablets show signs of discoloration, cracking, or if the expiration date has passed. Proper disposal of unused medication should follow local regulations.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Isoptin is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to therapy may vary, and treatment decisions should be based on comprehensive medical evaluation. Patients should not alter their dosage or discontinue medication without consulting their physician. The full prescribing information contains complete details regarding use, warnings, and precautions.
Reviews
Clinical studies demonstrate Isoptin’s efficacy in hypertension management with response rates of 60-70% as monotherapy. Meta-analyses show consistent blood pressure reduction of 10-15 mmHg systolic and 8-10 mmHg diastolic. In angina management, studies report 40-50% reduction in attack frequency and improved exercise tolerance. Cardiologists frequently note its value in patients with comorbid hypertension and atrial arrhythmias. Long-term safety data support its use with appropriate monitoring. Patient satisfaction surveys indicate good tolerability when constipation is proactively managed.